EPHX2 tool inhibitors have been reported to inhibit colitis and ulcer formation in dextran sodium sulfate (DSS)-induced, and in IL10 (interleukin 10) knockout mouse IBD models [12,13]. Here, EPHX2 is linked to inflammatory bowel disease.